Trial intelligence / Profile preview

Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate

2012-002969-35Phase 4Unknown

Sponsor
Imperial College London
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in myalgic encephalomyelitis (ME) comparing Sodium oxybate with Placebo (2 arms). Primary endpoint: Slow-wave activity. Status: unknown.

02

Drugs

sodium oxybate
03

Conditions

myalgic encephalomyelitis (ME)

Beyond the preview

Go deeper on 2012-002969-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002969-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call